
Fully Human Antibodies, Acceleration of Discovery & Development
Mission
First hospitalized COVID-19 patient treated with COR-101
YUMAB spin-off CORAT Therapeutics announced start of nationwide clinical trial.
Read press release
Breaking News


Individual Project Design, Fee for Service or Milestone-based
Contract Research, R&D Services
First hospitalized COVID-19 patient treated with COR-101
YUMAB spin-off CORAT Therapeutics announced start of nationwide clinical trial.
Read press release
Breaking News


Partnered R&D, Collaborations, Licensing
Pipeline & Partnering
First hospitalized COVID-19 patient treated with COR-101
YUMAB spin-off CORAT Therapeutics announced start of nationwide clinical trial.
Read press release
Breaking News
